2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

Which Primary Drivers Are Supporting the Continued Market Growth of theBreast Cancer Diagnostics Market?

The breast cancer diagnostics market is expected to grow due to the rising incidence of breast cancer. With breast cancer being the most common cancer among women, early detection plays a key role in reducing mortality rates. In 2022, the American Cancer Society estimated 287,850 new cases of invasive breast cancer in the U.S., making breast cancer diagnosis an urgent and necessary component of healthcare. The increasing need for diagnostic equipment to detect breast cancer at an early stage will drive market growth.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3284&type=smp

How Will the Growth Rate of theBreast Cancer Diagnostics Market Impact Industry Trends by 2034?

The breast cancer diagnostics market has experienced notable growth. It is expected to increase from $4.68 billion in 2024 to $5.04 billion in 2025, at a CAGR of 7.9%. This expansion has been driven by screening initiatives, widespread use of mammography, innovation in diagnostic technology, the rise in genetic testing, and integrated medical approaches.

The breast cancer diagnostics market will grow to $6.91 billion by 2029, at a CAGR of 8.2%. This growth is largely driven by innovations in imaging technologies, personalized medicine, liquid biopsies, and AI-driven diagnostic solutions. The development of 3D mammography (tomosynthesis) and telemedicine solutions will be key trends.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3284

How Are Consumer Market Innovations Shaping the Current and Future Landscape of theBreast Cancer Diagnostics Market?

Technological developments are significantly impacting the breast cancer diagnostics market. New diagnostic tools have emerged, such as 3D mammography, or breast tomosynthesis, which compiles multiple images to create a 3D breast model. In September 2022, Niramai, an Indian health-tech firm, introduced Thermalytix—a breast cancer detection solution that uses a combination of thermal imaging and artificial intelligence for automated screening and diagnosis.

Who Are the Key Market Players Influencing the Growth of the Corn and Breast Cancer Diagnostics Industry?

Major companies operating in the breast cancer diagnostics market include Abbott Laboratories, Myriad Genetics Inc., Hologic Inc., Koninklijke Philips N.V., Fujifilm Holdings Corporation, GE Healthcare, Thermo Fisher Scientific Inc., Siemens AG, NanoString Technologies Inc., Gamma Medica Inc., Aurora Imaging Technology Inc., Dilon Technologies Inc., Exact Sciences Corporation, F. Hoffmann-La Roche Ltd, Micrima Limited, Provista Diagnostics Inc., Leica Biosystems Nussloch GmbH, bioTheranostics Inc., Bio-Rad Laboratories Inc., Illumina Inc., Biocept Inc., Epigenomics AG, AstraZeneca plc, Quest Diagnostics Incorporated, Agilent Technologies Inc., Cepheid, Guardant Health Inc., Invitae Corporation, Natera Inc., NeoGenomics Laboratories Inc., Oncocyte Corporation, PerkinElmer Inc., Sysmex Corporation, Veracyte Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/breast-cancer-diagnostics-global-market-report

Which Key Market Segments Comprise the Breast Cancer Diagnostics Market and Drive Its Revenue Growth?

The breast cancer diagnostics market covered in this report is segmented –

1) By Type: Imaging, Biopsy, Genomic Tests, Blood Tests, Other Types

2) By Technology: Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Immunohistochemical (IHC), Other Technologies

3) By Cancer Type: BRCA Breast Cancer, ER And PR Breast Cancer, HER 2 Breast Cancer, EGFR Mutation Test Breast Cancer, Other Cancer Types

4) By Diagnostic Type: Ionizing Breast Imaging Technologies, Non-ionizing Imaging Technologies

5) By End Users: Hospitals And Clinics, Cancer Research Centers, Diagnostic Laboratories, Ambulatory Surgical Centers

Subsegments:

1) By Imaging: Mammography, Ultrasound Imaging, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Tomosynthesis

2) By Biopsy: Needle Biopsy, Core Needle Biopsy, Fine Needle Aspiration Biopsy (FNA), Stereotactic Biopsy

3) By Genomic Tests: Oncotype DX, MammaPrint, PAM50, BRCA1 Or 2 Testing

4) By Blood Tests: Liquid Biopsy, Circulating Tumor DNA (ctDNA) Tests, Circulating Tumor Cells (CTCs) Tests

5) By Other Types: Hormone Receptor Tests, HER2 Tests, Genetic Mutation Testing

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=3284&type=smp

Which Regions Are Emerging as Leaders in the Breast Cancer Diagnostics Market?

North America was the largest region in the breast cancer diagnostics market in 2023. Asia-Pacific was the second largest region in the breast cancer diagnostics industry. The regions covered in the breast cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Reports Similar to the Global Breast Cancer Diagnostics Market 2025, By The Business Research Company:

Breast Cancer Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/breast-cancer-drugs-global-market-report

Oncology Biosimilars Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/oncology-biosimilar-global-market-report

Cancer Diagnostics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: